Suppr超能文献

紫杉醇负载的普朗尼克P105聚合物胶束的制备、表征及对多药耐药肿瘤的体外逆转作用

[Preparation, characterization of paclitaxel-loaded Pluronic P105 polymeric micelles and in vitro reversal of multidrug resistant tumor].

作者信息

Wang Yong-Zhong, Fang Xiao-Ling, Li Ya-Juan, Zhang Zhi-Wen, Han Li-Mei, Sha Xian-Yi

机构信息

School of Pharmacy, Fudan University, Shanghai 200032, China.

出版信息

Yao Xue Xue Bao. 2008 Jun;43(6):640-6.

Abstract

Drug delivery system (DDS) is a novel approach to overcome multidrug resistance (MDR) in tumors nowadays. This work was designed to investigate a new micellar delivery system for in vitro reversal of resistant ovarian tumor cells, based on a nonionic triblock copolymer Pluronic P105 and paclitaxel (PTX). The PTX-loaded polymeric micelles (P105/PTX) were prepared by thin film-hydration methods. Based on the results of single factor experiments, the P105/PTX micelle formulation was optimized by employing the central composite design-response surface methodology. The physico-chemical properties of the P105/PTX micelles were characterized, including micelle size, drug loading coefficient, in vitro release behavior, etc. The cytotoxicity of the P105/PTX micelles was assessed against human ovarian tumor cell line, SKOV-3/PTX, by a standard 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl (MTT) assay. In order to understand the possible mechanism of Pluronic effects in resistant tumor cells, cellular uptake study of micellar PTX or Rhodamine-123 (R-123) was also carried out. The results showed that the micelle size was about 24 nm with drug loading coefficient of 1.1% and PTX concentration of 700 microg x mL(-1). The cumulative release amount of PTX from the P105/PTX micelles was only 45.4% in 6 h (P < 0.05) and 79.6% in 24 h, whereas Taxol injection in 6 h released 95.2% PTX. The IC50 values of the P105/PTX micelles and Taxol injection against SKOV-3/PTX were 1.14 and 5.11 microg x mL(-1), and resistance reversion index (RRI) was 9.65 and 2.15, respectively. The micellar PTX or R-123 exhibited a significant increase in cellular uptake in resistant SKOV-3/PTX cells compared with free PTX or R-123. These results indicated that PTX could effectively be solubilized by Pluronic P105 block copolymers via thin film-hydration process and formulation optimization, producing nano-scale polymeric micelles with sustained release property in vitro. The P105/PTX micelles were effectively able to reverse resistance to PTX in SKOV-3/PTX tumor cells compared with Taxol injection or free PTX solution, and the enhanced cytotoxicity in the resistant SKOV-3/PTX cell was related to the improved cellular uptake of PTX by Pluronic P105 copolymers.

摘要

药物递送系统(DDS)是目前克服肿瘤多药耐药性(MDR)的一种新方法。本研究旨在基于非离子三嵌段共聚物普朗尼克P105和紫杉醇(PTX),研究一种用于体外逆转耐药性卵巢肿瘤细胞的新型胶束递送系统。采用薄膜水化法制备了载PTX的聚合物胶束(P105/PTX)。基于单因素实验结果,采用中心复合设计-响应面法对P105/PTX胶束配方进行了优化。对P105/PTX胶束的物理化学性质进行了表征,包括胶束尺寸、载药系数、体外释放行为等。采用标准的3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴盐(MTT)法评估P105/PTX胶束对人卵巢肿瘤细胞系SKOV-3/PTX的细胞毒性。为了了解普朗尼克在耐药肿瘤细胞中的可能作用机制,还进行了胶束PTX或罗丹明-123(R-123)的细胞摄取研究。结果表明,胶束尺寸约为24nm,载药系数为1.1%,PTX浓度为700μg·mL-1。P105/PTX胶束中PTX的累积释放量在6h时仅为45.(此处原文可能有误,推测应为45.4%)4%(P<0.05),24h时为79.6%,而紫杉醇注射液在6h时释放95.2%的PTX。P105/PTX胶束和紫杉醇注射液对SKOV-3/PTX的IC50值分别为1.14和5.11μg·mL-1,耐药逆转指数(RRI)分别为9.65和2.15。与游离PTX或R-123相比,胶束PTX或R-123在耐药SKOV-3/PTX细胞中的细胞摄取显著增加。这些结果表明,通过薄膜水化过程和配方优化,PTX可被普朗尼克P105嵌段共聚物有效增溶,制备出具有体外缓释性能的纳米级聚合物胶束。与紫杉醇注射液或游离PTX溶液相比,P105/PTX胶束能够有效逆转SKOV-3/PTX肿瘤细胞对PTX的耐药性,耐药SKOV-3/PTX细胞中增强的细胞毒性与普朗尼克P105共聚物对PTX细胞摄取的改善有关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验